McGlinn Cancer Institute sees more than 1,500 new cancer diagnoses with a wide range of hematologic and oncologic diseases per year; as well as over 1,000 referrals of benign and hematologic malignancy cases. There are over 20 tumor boards each month and regular multidisciplinary clinics including breast, lung, gyn, GU, and GI malignancy. There is an active clinical research program that enrolls more than 100 patients/year in clinical trials and registries.